Upexi, Inc. (UPXI)
The price, the headline numbers and the latest news, in one place.
Upexi, Inc. (UPXI) Stock Price, Analysis & Data
| Bid | 1.03 |
| Market Cap | 78.6M |
| Revenue (ttm) | 26.1M |
| Net Income (ttm) | -228M |
| -0.24 | |
| 0.53 | |
| 2.02 | |
| -3.96 | |
| P/B (ttm) | -1.38 |
| P/S (ttm) | 3.01 |
| Earnings Date | Sep 24, 2026 |
| Ask | 1.12 |
| Volume | 6,324,376 |
| Avg. Volume (20D) | 2,193,074 |
| Open | 1.02 |
| Previous Close | 0.96 |
| Day's Range | 1.01 - 1.08 |
| 52-Week Range | 0.54 - 7.75 |
| Analyst | n/a |
| Price Target | 1.3 (21.5%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About UPXI
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesal...
Financial Performance
In 2025, Upexi's revenue was 15.81M, a decrease of -39.19% compared to the previous year's 26M. Earnings were -13.68M, a decrease of -42.16%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for UPXI stock is "null". The 12-month stock price forecast is 1.3, which is upside of 21.5% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $4.56M misses estimates by $0, with 44.19% YoY growth.
- EPS of -0.21 misses estimates by -0.14, with 91.25% YoY growth.
Analysts project revenue of ... Upgrade
